Correlation Between Arbutus Biopharma and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arbutus Biopharma Corp and Protagonist Therapeutics, you can compare the effects of market volatilities on Arbutus Biopharma and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and Protagonist Therapeutics.
Diversification Opportunities for Arbutus Biopharma and Protagonist Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Arbutus and Protagonist is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Arbutus Biopharma and Protagonist Therapeutics
Given the investment horizon of 90 days Arbutus Biopharma is expected to generate 4.18 times less return on investment than Protagonist Therapeutics. But when comparing it to its historical volatility, Arbutus Biopharma Corp is 1.6 times less risky than Protagonist Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,134 in Protagonist Therapeutics on August 31, 2024 and sell it today you would earn a total of 3,361 from holding Protagonist Therapeutics or generate 296.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arbutus Biopharma Corp vs. Protagonist Therapeutics
Performance |
| Timeline |
| Arbutus Biopharma Corp |
| Protagonist Therapeutics |
Arbutus Biopharma and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arbutus Biopharma and Protagonist Therapeutics
The main advantage of trading using opposite Arbutus Biopharma and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.| Arbutus Biopharma vs. ADMA Biologics | Arbutus Biopharma vs. Adaptimmune Therapeutics Plc | Arbutus Biopharma vs. Affimed NV | Arbutus Biopharma vs. Corvus Pharmaceuticals |
| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |